DIPNA PHARMACHEM LIMITED
DIPNA PHARMACHEM LIMITED having CIN L24100GJ2011PLC066400 is 13 years , 11 month & 4 days old Public Indian Company incorporated on 19 Jul 2011. It is classified as Non-government company and is registered at ROC Ahmedabad. Its authorized share capital is Rs. 250,000,000 and its paid up capital is Rs. 240,452,500. It's NIC code is 24100 (which is part of its CIN).
As per the NIC code, it is involved in . DIPNA PHARMACHEM LIMITED Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-29-2023. Directors of DIPNA PHARMACHEM LIMITED are Jitendra Pradipbhai Parmar and Chinu Kalal.
DIPNA PHARMACHEM LIMITED ' Corporate Identification Number (CIN) is L24100GJ2011PLC066400 and its registration number is 066400. Users may contact DIPNA PHARMACHEM LIMITED on its Email address - dharachem99@yahoo.in Registered address of DIPNA PHARMACHEM LIMITED is A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba,,Ahmedabad,Gujarat,India-380055. Current status of DIPNA PHARMACHEM LIMITED is - Active.
Key Indicators
as on 23/06/2025
as on 23/06/2025
Company Information
| CIN | L24100GJ2011PLC066400 |
|---|---|
| Company Status | Active |
| Registration Number | 066400 |
| Date of Incorporation | 07/19/2011 |
| RoC | ROC Ahmedabad |
| Company Age | 13 years & 343 days |
| Authorized Capital | ₹ 250000000 |
| Paid-up capital | ₹ 240452500 |
| Company Category | Company limited by shares |
| Company Sub-Category | Non-government company |
| Class of company | Public |
| Activity | |
| Listing status | listed |
| Date of Last Annual General Meeting | 31-03-2023 |
| Date of Latest Balance Sheet | 31-03-2023 |
Contact
| Email ID | dharachem99@yahoo.in |
|---|---|
| Address | A-211, SIDDHI VINAYAK COMPLEX, B/H. DCP OFFICE OFF C.G. ROAD HIGHWAY, MAKARBA AHMEDABAD Gujarat India 380051 |
| Website | yahoo.in |
| Contact Number | +91******* |
Location on Map
Director
| DIN | Name | Date OF Appointment | Designation | Tenure |
|---|---|---|---|---|
| 02507462 | 16 Feb 2023 | Director | 13 years | |
| 03167258 | 21 Feb 2023 | Director | 13 years | |
| 09565657 | 24 Feb 2023 | Director | 13 years | |
| 09568622 | 01 Jul 2023 | Director | 13 years | |
| 09699769 | 08 May 2023 | Director | 13 years |
Companies connected through Directors
| Name | Status | Paid Up Capital | Common Directors | Address |
|---|---|---|---|---|
| 1,00,000.00 | 2 | Gujarat | ||
| 20,00,000.00 | 2 | Maharashtra | ||
| 7,30,000.00 | 2 | Gujarat | ||
| 9,19,48,660.00 | 1 | Gujarat |
Charges on assets
Others
No. of Loans: 5
Total Amount: 145,849,000.00 cr
YES BANK LIMITED
No. of Loans: 1
Total Amount: 10,000,000.00 cr
| Charge Holder | Branch | Amount | Date of creation | Modification | Satisfaction | Status |
|---|---|---|---|---|---|---|
| Others | 2,300,000 | 29 Oct, 2022 | 16 Sep, 2023 | - | Open | |
| Others | 90,000,000 | 29 Oct, 2022 | 16 Sep, 2023 | - | Open | |
| Others | Plot No.C-3, G Block, BKC, Bandra East, | 21,500,000 | 09 Jun, 2021 | - | - | Open |
| Others | CONTONMENT | 28,500,000 | 18 Sep, 2015 | 26 Sep, 2018 | 31 Jul, 2023 | Closed |
| Others | CONTONMENT | 3,549,000 | 07 Aug, 2020 | - | 31 Jul, 2023 | Closed |
| YES BANK LIMITED | DR. ANNIE BESANT ROAD, WORLI, | 10,000,000 | 01 Jan, 2014 | 03 Mar, 2015 | 19 Nov, 2015 | Closed |
Registered Details
* There is the date provided by MCA, but availability for this year is not guaranteed.
Key Metrics
** All rupee values in INR crores. Based on March 2024 numbers.
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
9.29%
0.00%
Financial Highlights
** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales |
|
|
|
|
|
| Operating profit |
|
|
|
|
|
| Net profit |
|
|
|
|
|
| Gross margin |
|
|
|
|
|
| Operating margin |
|
|
|
|
|
| Net margin |
|
|
|
|
|
| Networth |
|
|
|
|
|
| Borrowings |
|
|
|
|
|
| Assets |
|
|
|
|
|
| Debt to equity |
|
|
|
|
|
| Current ratio |
|
|
|
|
|
| ROE |
|
|
|
|
|
| Days payable |
|
|
|
|
|
| WC days |
|
|
|
|
|
Balance Sheet
**** All numbers in INR
|
Mar 2020
|
Mar 2021
|
Mar 2022
|
Mar 2023
|
Mar 2024
|
|
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| (1) Shareholders‘ funds | |
|
|
|
|
| (a) Share capita | |
|
|
|
|
| (b) Reserves and surplus | |
|
|
|
|
| (c) Money received against share warrants | |
|
|
|
|
| (2) Share application money pending allotment | |
|
|
|
|
| (3) Non-current liabilities | |
|
|
|
|
| (a) Long-term borrowings | |
|
|
|
|
| (b) Deferred tax liabilities (Net) | |
|
|
|
|
| (c) Other Long-term liabilities | |
|
|
|
|
| (d) Long-term provisions | |
|
|
|
|
| (4) Current liabilities | |
|
|
|
|
| (a) Short-term borrowings | |
|
|
|
|
| (b) Trade payables | |
|
|
|
|
| (A) total outstanding dues of micro enterprises and small enterprises; and | |
|
|
|
|
| (B) total outstanding dues of creditors other than micro enterprises and small enterprises. | |
|
|
|
|
| (c) Other current liabilities | |
|
|
|
|
| (d) Short-term provisions | |
|
|
|
|
| Total | |
|
|
|
|
| ASSETS | |||||
| Non-current assets | |
|
|
|
|
| (a) [Property, Plant and Equipment] | |
|
|
|
|
| (i) Tangible assets | |
|
|
|
|
| (ii) Intangible assets | |
|
|
|
|
| (iii)Capital work-in-progress | |
|
|
|
|
| (iv) Intangible assets under development | |
|
|
|
|
| (b) Non-current investments | |
|
|
|
|
| (c) Deferred tax assets (net) | |
|
|
|
|
| (d) Long-term loans and advances | |
|
|
|
|
| (e) Other non-current assets | |
|
|
|
|
| (2) Current assets | |
|
|
|
|
| (a) Current investments | |
|
|
|
|
| (b) Inventories | |
|
|
|
|
| (c) Trade receivables | |
|
|
|
|
| (d) Cash and cash equivalents | |
|
|
|
|
| (e) Short-term loans and advances | |
|
|
|
|
| (f) Other current assets | |
|
|
|
|
| Total assets | |
|
|
|
|
| EQUITY AND LIABILITIES | ||||
| (1) Shareholders‘ funds | ||||
| (a) Share capital | ||||
| (b) Reserves and surplus | ||||
| (c) Money received against share warrants | ||||
| (2) Share application money pending allotment | ||||
| (3) Non-current liabilities | ||||
| (a) Long-term borrowings | ||||
| (b) Deferred tax liabilities (Net) | ||||
| (c) Other Long-term liabilities | ||||
| (d) Long-term provisions | ||||
| (4) Current liabilities | ||||
| (a) Short-term borrowings | ||||
| (b) Trade payables | ||||
| (A) total outstanding dues of micro enterprises and small enterprises; and | ||||
| (B) total outstanding dues of creditors other than micro enterprises and small enterprises. | ||||
| (c) Other current liabilities | ||||
| (d) Short-term provisions | ||||
| Total | ||||
| ASSETS | ||||
| Non-current assets | ||||
| (a) [Property, Plant and Equipment] | ||||
| (i) Tangible assets | ||||
| (ii) Intangible assets | ||||
| (iii)Capital work-in-progress | ||||
| (iv) Intangible assets under development | ||||
| (b) Non-current investments | ||||
| (c) Deferred tax assets (net) | ||||
| (d) Long-term loans and advances | ||||
| (e) Other non-current assets | ||||
| (2) Current assets | ||||
| (a) Current investments | ||||
| (b) Inventories | ||||
| (c) Trade receivables | ||||
| (d) Cash and cash equivalents | ||||
| (e) Short-term loans and advances | ||||
| (f) Other current assets | ||||
| Total assets | ||||
Profit & Loss
**** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| I.Revenue from operations | |
|
|
|
|
| II. Other income | |
|
|
|
|
| III.Total Revenue (I + II) | |
|
|
|
|
| IV.Expenses | |
|
|
|
|
| (1)Cost of materials consumed | |
|
|
|
|
| (2)Purchases of Stock-in-Trade | |
|
|
|
|
| (3)Changes in inventories of finished goods work-in-progress and | |
|
|
|
|
| (4)Stock-in-Trade | |
|
|
|
|
| (5)Employee benefits expense | |
|
|
|
|
| (6)Finance costs | |
|
|
|
|
| (7)Depreciation and amortisation expense | |
|
|
|
|
| (8)Other expenses | |
|
|
|
|
| (9)Total expenses | |
|
|
|
|
| VProfit before exceptional and extraordinary items and tax (III - IV) | |
|
|
|
|
| VIExceptional items | |
|
|
|
|
| VII.Profit before extraordinary items and tax (V - VI) | |
|
|
|
|
| VIII.Extraordinary items | |
|
|
|
|
| IX.Profit before tax (VII- VIII) | |
|
|
|
|
| X. Tax expense: | |
|
|
|
|
| (1)Current tax | |
|
|
|
|
| (2)Deferred tax | |
|
|
|
|
| XI.Profit (Loss) for the period from continuing operations (VII-VIII) | |
|
|
|
|
| XII.Profit/(loss) from discontinuing operations | |
|
|
|
|
| XIII.Tax expense of discontinuing operations | |
|
|
|
|
| XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) | |
|
|
|
|
| XV.Profit (Loss) for the period (XI + XIV) | |
|
|
|
|
| XVI.Earnings per equity share: | |
|
|
|
|
| (1) Basic | |
|
|
|
|
| (2)Diluted | |
|
|
|
|
| Precentage of total incomex |
|---|
Ratio
** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt/Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Liquidity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Performance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-tax ROCE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-tax ROIC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Subsidiaries, Associate Companies & Join Ventures of Dipna Pharmachem Limited
| Company Identifier | Name | Percentage of Shares Held |
|---|---|---|
|
|
|
|
|
|
|
|
|
Fund Raising Activity of Dipna Pharmachem Limited
| Date of Allotment | Securities Alloted | Terms | Number of Securities | Nominal Amount | Premium Amount Due & Payable | Premium Amount Paid | Total Discount | Amount to be Paid on Calls (Excluding Premium) | Attachments |
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board Meetings of Dipna Pharmachem Limited
| Date of Filing | Date of Dispatch of Notice | Section (Companies Act 2013) | Purpose of passing the resolution | Subject Matter of Resolution | Resolution Agreed By | Special Resolution | Address |
|---|
Auditors of Dipna Pharmachem Limited
| Financial Year | Name of Auditor or Firm | PAN of Auditor or Firm | Membership Number | Registration Number | Address |
|---|
Outstanding Payments to Micro & Small Enterprises
| Filing Type | As On | Amount Due to MSME | Current Liabilities | Ratio to Current Liabilities | Reasons for Delay |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Complaints & Serious Complaints About Dipna Pharmachem Limited
Director Complain
| Date | DIN | Cessation Date | Cessation Reason | Complaint |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serious Complaints
| Date | Complaint | Other |
|---|---|---|
|
|
|
|
|
|
|
|
|
Investor Complaints & Other Complaints
| Date | Complaint Type | Complaint Sub Type | Particulars of Secutiries | Period | Complaint | Other Details |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prosecution Details of Dipna Pharmachem Limited
| S.No. | Defaulting Entities | Court Name | Prosecution Section | Date of Order | Status |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FAQs- Dipna Pharmachem Limited
DIPNA PHARMACHEM LIMITED having CIN L24100GJ2011PLC066400 is 13 years , 11 month old Public Indian Company incorporated with MCA on 08 May 2023. DIPNA PHARMACHEM LIMITED is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Ahmedabad with an Authorized Share Capital of 250,000,000 and paid-up capital is 240,452,500.
CIN of DIPNA PHARMACHEM LIMITED is L24100GJ2011PLC066400.
Address of DIPNA PHARMACHEM LIMITED is A/211, siddhi vinayak complex, near d.a.v. school, makarba,,ahmedabad,gujarat,india-380055,.
The company has 13 directors/key management personnel Dipna Shah,keyur Shah,khushboo Jethaliya,keyur Parmar,dipna Shah,keyur Shah,. .,nandish Jani,chinu Kalal,nandish Jani,jitendra Parmar,madhuri Gurwani,chinu Kalal,
Email : dharachem99@yahoo.in
Address : A-211, SIDDHI VINAYAK COMPLEX, B/H. DCP OFFICE OFF C.G. ROAD HIGHWAY, MAKARBA AHMEDABAD Gujarat India 380051
DIPNA PHARMACHEM LIMITED is involved in activities such as Computer programming, consultancy and related activities
Popular Services
Popular Search
Top Companies in your State
- ANANGESHWAR PARWATI RAMANUGRAH PROJECTS PRIVATE LIMITED
- BEAVER TECHNOCRATE PRIVATE LIMITED
- BUSINESS LINE (ISPAT) PRIVATE LIMITED
- HARIOM ROHAN CONSTRUCTION PRIVATE LIMITED
- HIMALIYA DEVELOPERS INDIA PRIVATE LIMITED
- INDRA RANI CONSTRCTION AND SUPPLIERS PRIVATE LIMITED
- MAA SINHASINI INFRASTRUCTURE PRIVATE LIMITED
- MOTIVE BROKING & ADVISORY PRIVATE LIMITED
- NIRSHILP COMMODITIES AND TRADING PRIVATE LIMITED
- OMNIBUS INDUSTRIAL DEVELOPMENT CORPORATION OF DAMAN DIU AND DADRA NAGAR HAVELI LIMITED
- PRIMECOUNSEL PRIVATE LIMITED
- QCAP SECURITIES PRIVATE LIMITED
- SHAAFIA FOREX PRIVATE LIMITED
- SMIT (DAMAN) ESTATES PRIVATE LIMITED
- ALBEMARLE CHEMICALS PRIVATE LIMITED
- BEYOND BORDERS TRAVEL MANAGEMENT CO PRIVATE LIMITED
- COEUS EDUCATION MANAGEMENT PRIVATE LIMITED
- COFCO INTERNATIONAL INDIA PRIVATE LIMITED
- EVOTEK HYDRAULIC TECHNOLOGY INDIA PRIVATE LIMITED
- EXXONMOBIL COMPANY INDIA PRIVATE LIMITED
- HALITE PERSONAL CARE INDIA PRIVATE LIMITED
Exclusive Access 